QP 32 - PRO 2: Quick Pitch:

Presentations

• 05:05pm - 05:10pm ET

  Stereotactic Ablative Radiotherapy for High-Risk Prostate Cancer — Long Term Results of a Prospective Multi-Level MRI-Based Dose Escalation Trial

  Speaker: Akrita Bhatnagar, MD, PhD - Georgetown - Lombardi Cancer Center and Georgetown Medical School, Washington DC
• 05:10pm - 05:15pm ET

  Age at Irradiation Modifies the Risk of Radiation-Associated Hypogonadism in Male Pediatric Cancer Survivors

  Speaker: Sujith Baliga, MD - The Ohio State University , Dublin
• 05:15pm - 05:20pm ET

  Development Stage-Specific Breast Dose Reconstruction In Childhood Cancer Survivors: A New Foundation for Subsequent Breast Cancer Risk Modeling

  Speaker: Taylor Meyers, MS, BS - The University of Texas MD Anderson Cancer Center, Houston
• 05:20pm - 05:25pm ET

  Individual Differences in Resilience and Optimism May Complicate the Interpretation of PROMs Commonly Used in Oncology Trials: Results from a Prospective Longitudinal Observational Study

  Speaker: Lachlan McDowell, PhD, MBBS, FRANZCR - Princess Alexandra Hospital, Woolloongabba
• 05:25pm - 05:30pm ET

  Swallowing Outcomes with Intensive Midline-Sparing IMRT in Nasopharyngeal Carcinoma

  Speaker: Janjira Petsuksiri, MD - Siriraj Hospital, Bangkoknoi
• 05:30pm - 05:35pm ET

  Longitudinal Trajectories, Quality Of Life Impact, and Intervention Thresholds of Radiation-Induced Adverse Events in Head And Neck Cancer: An ePRO-Based Cohort Study

  Speaker: Peng Zhang, MD - Sichuan Cancer Hospital and Institute, Chengdu